NCT03926299View on ClinicalTrials.gov

Clinical Trial to Demonstrate That the Dual Laser Therapy is Effective for the Treatment of Vulvar Lichen Sclerosus

NAActive, not recruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 15, 2019

Primary Completion Date

July 30, 2024

Study Completion Date

July 30, 2024

Conditions
Chronic Skin DiseaseVulvar Lichen Sclerosus
Interventions
DEVICE

FotonaSmooth SP® Spectro laser device

dual laser treatment with thermal Nd:YAG and ablative Er:YAG (Fotona medical device), 4 laser sessions 4-8 weeks apart.

DRUG

Clobetasol propionate 0.05% ointment

6 months standard treatment with topical steroid cream (high dose for the first two months, medium dose for the next two months, low dose for the last two months)

Trial Locations (1)

8501

Cantonal Hospital Frauenfeld, Frauenfeld

All Listed Sponsors
lead

Prof. Dr. Volker Viereck

OTHER